[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346472-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346472-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","an-oncogenic-kras-driven-secretome-involving-tnf-promotes-niche-preparation-prior-to-pancreatic-cancer-onset","An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset","","Oncogenic KRAS is a central driver of pancreatic ductal adenocarcinoma, yet pre-invasive molecular programs and their effects on the surrounding niche remain insufficiently defined. Using time-resolved single-cell RNA sequencing and accessible-chromatin profiling in KRASG12D-inducible human pancreatic duct-like organoids and niche cells, the study maps epithelium-to-niche communication. Machine learning identifies KRASG12D-dependent classifiers, while co-culture experiments show that the KRASG12D secretome activates pancreatic stellate cells and shields precancerous organoids from T-cell infiltration.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/an-oncogenic-kras-driven-secretome-involving-tnf-promotes-niche-preparation-prior-to-pancreatic-cancer-onset/346472/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/an-oncogenic-kras-driven-secretome-involving-tnf-promotes-niche-preparation-prior-to-pancreatic-cancer-onset/346472.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study trying to uncover about pancreatic cancer development?","Question",{"text":63,"@type":64},"The study investigates molecular changes in the precancerous epithelium and the surrounding niche that occur before invasive growth, particularly how oncogenic KRAS shapes these early programs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which experimental technologies were used to analyze KRAS-driven changes?",{"text":68,"@type":64},"Time-resolved single-cell transcriptomic profiling (scRNAseq) and accessible-chromatin data were generated from KRASG12D-inducible pancreatic duct-like organoids and various niche cells.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the KRAS-driven secretome affect the niche and immune cells?",{"text":72,"@type":64},"The KRASG12D-induced PDLO secretome activates pancreatic stellate cells and protects precancerous organoids from T-cell infiltration, including evidence for T-cell shielding mediated by TNFα.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346472,1790194396,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Allgöwer etal. Molecular Cancer (2026) 25:29 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02541-1](https://doi.org/10.1186/s12943-025-02541-1)  \nRESEARCH Open Access  \nAn oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset  \nChantal Allgöwer1, Medhanie A. Mulaw2, James Nagai3, Sandra Wiedenmann4, Elena Anne Ringel1,  \nBenedetta Ferrara5, Lorenzo Piemonti5,6, Tengku Ibrahim Maulana7,8,9, LuisaT. Ferreira 10, Adam Flinders 10, Claudia Teufel7,8, Leon Reichardt 1, Paul B. Lopatta 1, Dharini Srinivasan1, Anton Lahusen 11, Thomas Seufferlein11, Nadine Therese Gaisa12, Annika Beck 12, Jessica Lindenmayer 13, Michael K. Melzer 1,14, Eleni Zimmer1, Elodie Roger1, Sandra Heller 1, J.-Mathias Löhr 15, Stefan Liebau 16, Peter Loskill7,8,9, Yuan-Na Lin 11, Paolo Riccardo Camisa5,6,17, Claus Jorgensen10, Stefano Crippa6,17, Matthias Meier4,18, Meike Hohwieler1, Ivan G. Costa3, Markus Breunig1*† and Alexander Kleger1,13,19*†  \nAbstract  \nBackground Pancreatic ductal adenocarcinomas (PDACs) are highly lethal and aggressive with oncogenic KRAS being the main oncogenic driver of the disease. PDACs have been extensively profiled at advanced stages, and in advanced disease the tumor microenvironment is a major determinant that critically shapes patient outcomes. Since the molecular events occurring prior to invasive growth remain poorly understood, we aimed to investigate changes in the precancerous epithelium and its surrounding niche.  \nMethods We acquired time-resolved, single-cell transcriptomic (scRNAseq), and accessible-chromatin data from human pluripotent stem cell-derived pancreatic duct-like organoids (PDLO) inducibly expressing KRASG12D and from various niche cells.  \nResults Analysis of the pure epithelium already revealed key signatures of matrix remodeling and inflammationrelated signaling upon few days of KRASG12D expression. Machine learning captured KRASG12D-dependent transcriptomic classifiers with high prediction accuracy and niche preparatory relevance. Various co-culture approaches followed by scRNAseq and functional validation, including T-cell microfluidics, demonstrated that the KRASG12D-induced PDLO-secretome activates pancreatic stellate cells (PaSCs) and protects precancerous organoids from T cell infiltration. Additional, in silico approaches reconstructed a virtual pancreatic (pre)cancerous space  \n†Markus Breunig and Alexander Kleger jointly supervised this work and contributed equally.  \n*Correspondence:  \nMarkus Breunig [markus.breunig@uni-ulm.de](markus.breunig@uni-ulm.de)[ ](markus.breunig@uni-ulm.de)Alexander Kleger  \nalexander.kleger@uni-ulm.de  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nAllgöwer et al. Molecular Cancer (2026) 25:29 Page 2 of 32  \nto profile cell–cell interactions between PDLOs and niche cells. TNFα emerged as a top-ranked ligand and was functionally validated to mediateT-cell shielding and PaSC activation. Cyst fluid from 80 prospectively sampled","cbCaimbpX2aILBOz","https://ap.wps.com/l/cbCaimbpX2aILBOz","pdf",15453550,32,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the study trying to uncover about pancreatic cancer development?\",\"answer\":\"The study investigates molecular changes in the precancerous epithelium and the surrounding niche that occur before invasive growth, particularly how oncogenic KRAS shapes these early programs.\"},{\"question\":\"Which experimental technologies were used to analyze KRAS-driven changes?\",\"answer\":\"Time-resolved single-cell transcriptomic profiling (scRNAseq) and accessible-chromatin data were generated from KRASG12D-inducible pancreatic duct-like organoids and various niche cells.\"},{\"question\":\"How does the KRAS-driven secretome affect the niche and immune cells?\",\"answer\":\"The KRASG12D-induced PDLO secretome activates pancreatic stellate cells and protects precancerous organoids from T-cell infiltration, including evidence for T-cell shielding mediated by TNFα.\"}]","An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset | PDF",1790061573,81,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87421b360315bacbc706caa33a848881.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cda9dcb017f7a9c73bcbc643bb88afc.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2d4cb08f47d2ae6ec117a59bf3f3921.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6a8f450ad4d6ba1677baade46d5c72d.webp",980,1306]